Immunological recovery after 3 years' antiretroviral therapy in HIV-1-infected children

AIDS

Volumn 16, Issue 3, 2002, Pages 483-486

  Resino, Salvador ^a   Sanchez Ramón, Silvia ^a   Bellón, José Ma ^a   Correa, Rafael ^a   Abad, Ma Luisa ^a   Muñoz Fernández, Ma Ángeles ^a  

^a HOSPITAL GENERAL UNIVERSITARIO GREGORIO MARAÑÓN   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT;

ANTIMICROBIAL THERAPY; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE SYSTEM; LYMPHOCYTE COUNT; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SCHOOL CHILD;

ANTI-HIV AGENTS; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; CASE-CONTROL STUDIES; CD4 LYMPHOCYTE COUNT; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CHILD; DNA, VIRAL; GENE REARRANGEMENT, T-LYMPHOCYTE; HIV INFECTIONS; HIV-1; HUMANS; IMMUNOLOGIC MEMORY; LONGITUDINAL STUDIES; LYMPHOCYTE ACTIVATION; RETROSPECTIVE STUDIES; TIME FACTORS;

EID: 0037084239     PISSN: 02699370     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002030-200202150-00022     Document Type: Article

References (9)

1. Impaired IL-5 production by T cells as prognostic marker of disease progression in HIV-1-infected children
2. Biphasic kinetics of peripheral blood T cells after triple combination therapy in HIV-1 infection: A composite of redistribution and proliferation
3. Elevated CD38 antigen expression on CD8+ T cells is a stronger marker for the risk of chronic HIV disease progression to AIDS and death in the Multicenter AIDS Cohort Study than CD4+ cell count, soluble immune activation markers, or combinations of HLA-DR and CD38 expression
4. Different meaning of CD38 molecule expression on CD4+ and CD8+ cells of children perinatally infected with human immunodeficiency virus type 1 infection surviving longer than five years
5. Relationship between CD4+ T-lymphocyte subsets and the laboratory markers used to monitor the HIV-1 infection in children with potent antirretroviral therapy
6. Viral phenotype affects the thymical production of new T-cells in HIV-1 infected children
7. Differential responses of T cell subsets: Possible role in the immunopathogenesis of AIDS
8. Expression of CD38 on CD8 T cells predicts maintenance of high viraemia in HAART-treated HIV-1-infected children. Highly active antiretroviral therapy
9. Effect of HIV on thymic function before and after antiretroviral therapy in children